Bionano Genomics, Inc.
BNGO
$3.27
$0.123.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -121.02% | 84.59% | 54.52% | -172.72% | 48.37% |
| Total Depreciation and Amortization | -2.17% | 1.47% | -56.88% | 86.90% | -0.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.79% | -146.82% | -62.98% | 801.05% | 32.27% |
| Change in Net Operating Assets | -137.72% | -10.68% | 89.22% | 127.45% | -182.28% |
| Cash from Operations | -26.16% | 57.50% | 51.13% | 36.56% | 25.43% |
| Capital Expenditure | -- | -- | -- | 100.00% | -196.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 114.07% | -569.34% | 155.76% | -118.72% | -39.70% |
| Cash from Investing | 114.07% | -569.34% | 155.76% | -118.77% | -39.83% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -18,762.50% | 99.21% | 33.20% | 88.31% | 29.67% |
| Issuance of Common Stock | -76.80% | 98.24% | -33.52% | -16.90% | -21.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 157.71% | -195.72% | 23.98% | 83.06% | -1,545.34% |
| Cash from Financing | -86.51% | 179.97% | -35.39% | 404.40% | 90.85% |
| Foreign Exchange rate Adjustments | -166.67% | -125.00% | -116.67% | 2,500.00% | 96.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.94% | -1,669.39% | 103.00% | -322.75% | 359.21% |